Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab.

Walraven M, Homs MYV, van der Veldt AAM, Dekker H, Koldenhof J, Honeywell R, Barendrecht A, Sebastian SAE, Parr N, Koekman AC, Voest EE, Roest M, Korporaal SJA, Verheul HMW.

Angiogenesis. 2018 May;21(2):325-334. doi: 10.1007/s10456-018-9598-5. Epub 2018 Mar 12.

2.

Therapeutic approaches to control tissue repair and fibrosis: Extracellular matrix as a game changer.

Walraven M, Hinz B.

Matrix Biol. 2018 Oct;71-72:205-224. doi: 10.1016/j.matbio.2018.02.020. Epub 2018 Feb 27. Review.

PMID:
29499355
3.

Pazopanib-related tumor lysis syndrome in metastatic clear cell renal cell carcinoma: a case report.

van Kalleveen MW, Walraven M, Hendriks MP.

Invest New Drugs. 2018 Jun;36(3):513-516. doi: 10.1007/s10637-018-0576-y. Epub 2018 Feb 20.

PMID:
29464464
4.

The fibronectin ED-A domain enhances recruitment of latent TGF-β-binding protein-1 to the fibroblast matrix.

Klingberg F, Chau G, Walraven M, Boo S, Koehler A, Chow ML, Olsen AL, Im M, Lodyga M, Wells RG, White ES, Hinz B.

J Cell Sci. 2018 Mar 1;131(5). pii: jcs201293. doi: 10.1242/jcs.201293.

5.

In vitro cultured fetal fibroblasts have myofibroblast-associated characteristics and produce a fibrotic-like environment upon stimulation with TGF-β1: Is there a thin line between fetal scarless healing and fibrosis?

Walraven M, Akershoek JJ, Beelen RH, Ulrich MM.

Arch Dermatol Res. 2017 Mar;309(2):111-121. doi: 10.1007/s00403-016-1710-3. Epub 2016 Dec 21.

PMID:
28004279
6.

A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer.

Wentink MQ, Broxterman HJ, Lam SW, Boven E, Walraven M, Griffioen AW, Pili R, van der Vliet HJ, de Gruijl TD, Verheul HM.

Br J Cancer. 2016 Oct 11;115(8):940-948. doi: 10.1038/bjc.2016.275. Epub 2016 Aug 30.

7.

Blocking α1-integrin reverts the adhesive phenotype of adult fibroblasts towards a foetal-like migratory phenotype.

Walraven M, van Vliet SJ, Beelen RH, van Egmond M, Ulrich MM.

Exp Dermatol. 2016 Jun;25(6):480-2. doi: 10.1111/exd.12977. Epub 2016 May 6. No abstract available.

PMID:
27294728
8.

Healthy human second-trimester fetal skin is deficient in leukocytes and associated homing chemokines.

Walraven M, Talhout W, Beelen RH, van Egmond M, Ulrich MM.

Wound Repair Regen. 2016 May;24(3):533-41. doi: 10.1111/wrr.12421. Epub 2016 Mar 16.

PMID:
26873861
9.

Transforming growth factor-β (TGF-β) signaling in healthy human fetal skin: a descriptive study.

Walraven M, Beelen RH, Ulrich MM.

J Dermatol Sci. 2015 May;78(2):117-24. doi: 10.1016/j.jdermsci.2015.02.012. Epub 2015 Feb 26.

PMID:
25795202
10.

Symptoms from treatment with sunitinib or sorafenib: a multicenter explorative cohort study to explore the influence of patient-reported outcomes on therapy decisions.

Koldenhof JJ, Witteveen PO, de Vos R, Walraven M, Tillier CN, Verheul HM, Teunissen SC.

Support Care Cancer. 2014 Sep;22(9):2371-80. doi: 10.1007/s00520-014-2223-2. Epub 2014 Apr 2.

PMID:
24687539
11.

Altered TGF-β signaling in fetal fibroblasts: what is known about the underlying mechanisms?

Walraven M, Gouverneur M, Middelkoop E, Beelen RH, Ulrich MM.

Wound Repair Regen. 2014 Jan-Feb;22(1):3-13. doi: 10.1111/wrr.12098. Epub 2013 Oct 17. Review.

PMID:
24134669
12.

Tissue engineered tubular construct for urinary diversion in a preclinical porcine model.

Geutjes P, Roelofs L, Hoogenkamp H, Walraven M, Kortmann B, de Gier R, Farag F, Tiemessen D, Sloff M, Oosterwijk E, van Kuppevelt T, Daamen W, Feitz W.

J Urol. 2012 Aug;188(2):653-60. doi: 10.1016/j.juro.2012.03.119. Epub 2012 Jun 15.

PMID:
22704444
13.

Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs.

Van der Veldt AA, Lubberink M, Bahce I, Walraven M, de Boer MP, Greuter HN, Hendrikse NH, Eriksson J, Windhorst AD, Postmus PE, Verheul HM, Serné EH, Lammertsma AA, Smit EF.

Cancer Cell. 2012 Jan 17;21(1):82-91. doi: 10.1016/j.ccr.2011.11.023.

14.

Targeting the endothelin axis with atrasentan, in combination with IFN-alpha, in metastatic renal cell carcinoma.

Groenewegen G, Walraven M, Vermaat J, de Gast B, Witteveen E, Giles R, Haanen J, Voest E.

Br J Cancer. 2012 Jan 17;106(2):284-9. doi: 10.1038/bjc.2011.515. Epub 2012 Jan 3.

15.

Blood platelets contain tumor-derived RNA biomarkers.

Nilsson RJ, Balaj L, Hulleman E, van Rijn S, Pegtel DM, Walraven M, Widmark A, Gerritsen WR, Verheul HM, Vandertop WP, Noske DP, Skog J, Würdinger T.

Blood. 2011 Sep 29;118(13):3680-3. doi: 10.1182/blood-2011-03-344408. Epub 2011 Aug 10.

PMID:
21832279
16.

Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review.

Walraven M, Witteveen PO, Lolkema MP, van Hillegersberg R, Voest EE, Verheul HM.

Angiogenesis. 2011 May;14(2):135-41. doi: 10.1007/s10456-010-9197-6. Epub 2010 Dec 29. Review.

17.

Simple and selective method for the determination of various tyrosine kinase inhibitors used in the clinical setting by liquid chromatography tandem mass spectrometry.

Honeywell R, Yarzadah K, Giovannetti E, Losekoot N, Smit EF, Walraven M, Lind JS, Tibaldi C, Verheul HM, Peters GJ.

J Chromatogr B Analyt Technol Biomed Life Sci. 2010 May 1;878(15-16):1059-68. doi: 10.1016/j.jchromb.2010.03.010. Epub 2010 Mar 15.

PMID:
20382575
18.

[Three patients with gynaecomastia].

Walraven M, Wilmink HJ, de Boer LM, Muller AF.

Ned Tijdschr Geneeskd. 2004 Apr 24;148(17):809-13. Dutch.

PMID:
15141644

Supplemental Content

Loading ...
Support Center